USDA announced $30 million American Rescue Plan funding opportunity supporting research on SARS-CoV-2 in animals
On Nov. 1, 2022, the U.S. Department of Agriculture announced it was making $30 million in American Rescue…
-
-
JAMA reported alcohol related deaths due to excessive alcohol use among US adults 2015 to 2019
On Nov. 1, 2022, study results published in JAMA found that estimates in this cross-sectional study of 694,660…
-
Zimbabwe became first in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention
On Nov. 1, 2022, the Medicines Control Authority of Zimbabwe announced that it had approved the use of…
-
Biotechnology | COVID-19 | Diagnostics | Disease | NIH | Therapeutics
NIH-funded study showed blood pressure levels rose during pandemic
On Nov. 1, 2022, the National Institutes of Health (NIH) announced that adults with hypertension saw a small,…
-
Monoclonal antibody prevented Malaria infection in African adults
On Oct. 31, 2022, the National Institutes of Health announced that a clinical trial had found that one…
-
Japan approved partial change to a NDA for Omicron-targeting bivalent booster COVID-19 vaccine
On Oct. 31, 2022, Moderna announced that it had received approval from the Ministry of Health, Labour and…
-
Abbott’s FreeStyle Libreﾮ was named Best Medical Technology in Last 50 Years by the Galien Foundation
On Sept. 3, 2014, the Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences,…
-
INOVIO Discontinued internal efforts to develop INO-4800 as COVID-19 heterologous booster vaccine Candidate
On Oct. 27, 2022, Inovio Pharma announced that it has discontinued its internally funded efforts to develop INO-4800…
-
USDA dashboard shows broad view of Avian influenza in wild birds by U.S. County
On Oct. 27, 2022, the U.S. Department of Agriculture’s Animal Plant Health Inspection Service (APHIS) confirmed the presence…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Therapeutics
Reported cancer deaths continued downward trend; modest improvements in survival for pancreatic cancer
On Oct. 27, 2022, the National Institutes of Health (NIH) announced that overall cancer death rates continued to…
-
Tuberculosis deaths and disease increased during the COVID-19 pandemic
On Oct. 27, 2022, the World Health Organization reported that an estimated 10.6 million people fell ill with…
-
Karmanos completed $48 million expansion at Farmington Hills cancer center
On Oct. 26, 2022, the Barbara Ann Karmanos Cancer Institute announced it had completed an over 50,000-square-foot expansion…
-
NIH awarded USC $11.7 million to develop implantable devices for the nervous system
On Oct. 26, 2022, the NIH announced it had awarded the University of Southern California (USC) $11.7 million…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Nanotechnology | Therapeutics | Vaccine
COVID-causing virus in air detected with high-tech bubbles
On Oct. 25, 2022, Pacific Northwest National Laboratory (PNNL) announced that scientists have shown that they can detect…
-
University of Washington reported global COVID cases will increase in coming months, but at a slower pace
On Oct. 25, 2022, the University of Washington reported that daily global COVID-19 infections were projected to rise…
-
NIH awarded University of Missouri $8 million grant to expand National Swine Resource and Research Center
On Oct. 25, 2022, the National Institutes of Health (NIH) announced that the University of Missouri had been…
-
EC expanded Merckﾒs VAXNEUVANCEﾙ indication to include infants, children and adolescents
On Oct. 24, 2022, Merck announced that the European Commission had approved an expanded indication for VAXNEUVANCEﾙ (Pneumococcal…
-
Biotechnology | HIV | NIH
Early HIV diagnosis and treatment important for better long-term health outcomes
On Oct. 24, 2022, the National Institutes of Health announced that starting antiretroviral treatment (ART) early in the…
-
Biotechnology | HIV | NIH | Vaccine
Three-dose hepatitis B vaccine regimen protected people with HIV
On Oct. 20, 2022, the National Institutes of Health announced that a three-dose course of the hepatitis B…
-
Study confirmed safety of shingles vaccine
On Oct. 20, 2022, published results supported previous findings that the recombinant zoster vaccine Shingrix, recommended by the…
-
FDA finalized historic rule enabling access to Over-the-Counter hearing aids for millions of Americans
On Oct. 19, 2022, the U.S. Food and Drug Administration final rule establishing Over-the-Counter Hearing Aids to improve…
-
90-Day analysis showed Moderna’s Omicron BA.1-targeting bivalent vaccine, mRNA-1273.214, demonstrated superior antibody response
On Oct. 19, 2022, Moderna announced new clinical data on its bivalent Omicron-containing booster, mRNA-1273.214. Ninety days after…
-
EMA’s CHMP for Human Use issued positive opinion recommending authorization for use of Spikevax in children 6 months – 5 years in EU
On Oct. 19, 2022, Moderna announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…
-
U.S. FDA recommended Novavax COVID-19 vaccine, adjuvanted as a booster in adults
On Oct. 19, 2022, the U.S. Food and Drug Administration (FDA) recommended the use of the Novavax COVID-19…
-
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO
Global leaders committed US$ 2.6 billion at World Health Summit to end polio
On Oct. 18, 2022, global leaders confirmed US$ 2.6 billion in funding toward the Global Polio Eradication Initiative’s…
-
Moderna announced supply agreement with Gavi that secured access to updated variant-specific COVID-19 vaccines for low-and-middle income countries
On Oct. 17, 2022, Moderna and Gavi, the Vaccine Alliance, announced they had mutually agreed to cancel remaining…
-
DNA evidence of plague found in Central Asia
On Oct. 15, 2022, scientists reported that DNA evidence showed that the plague infection was endemic in the…
-
Novavax COVID-19-influenza combination vaccine candidate induced antibody and T-Cell responses against SARS-CoV-2 and influenza
On Oct. 13, 2022, Novavax announced positive results from the Phase 1/2 clinical trial of its COVID-19-Influenza Combination…
-
Honeycrisp apple genome was completed
On Oct. 13, 2022, a team of researchers led by Cornell University announced they had sequenced the Honeycrisp…
-
Pfizer and BioNTech announced positive early data from clinical trial of Omicron BA.4/BA.5-adapted bivalent booster
On Oct. 13, 2022, Pfizer and BioNTech announced early data from a Phase 2/3 clinical trial (NCT05472038) evaluating…
